http://www.newsinferno.com/archives/3370
and the official notice
http://www.rocheusa.com/products/cel...ML_May2008.pdf
I see NO notice of the FDA requiring a black label, a TOUCH-like program or any of the other hoops that Tysabri has had to put in place. That doesn't mean it isn't coming...but makes me wonder WHY, with ALL the drugs out there on the market now that have been associated with PML, natalizumab continues to be singled out after TWO years on the market without a SINGLE case of PML.